Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Upadacitinib may effectively treat alopecia areata without side effects.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Baricitinib shows promise for treating alopecia areata with mild side effects.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Ruxolitinib helped a patient with alopecia areata regrow hair.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Mouse Notch is important for determining cell roles in hair follicles.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

JAK inhibitors may help treat alopecia areata by reversing hair loss.